Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Walgreens Boots Alliance Inc    

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Costco says cooperating with DEA probe on controlled substances

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/17/2013 | 12:05am CET

Costco Wholesale Corp (>> Costco Wholesale Corporation) said on Wednesday that it will cooperate with the U.S. Drug Enforcement Administration in its ongoing investigation of prescriptions for controlled substances, after receiving subpoenas and warrants from the DEA.

Costco Wholesale Corp (>> Costco Wholesale Corporation) said on Wednesday that it will cooperate with the U.S. Drug Enforcement Administration in its ongoing investigation of prescriptions for controlled substances, after receiving subpoenas and warrants from the DEA.

The DEA has targeted large pharmacy chains and distributors to stem the flow of prescription drugs where abuse is suspected.

The DEA revoked the controlled substance licenses of two CVS Caremark Corp (>> CVS Caremark Corporation) drugstores in Florida in 2012, and earlier this year Walgreen Co (>> Walgreen Company) reached a record $80 million settlement with the agency to resolve allegations that its negligence in record-keeping and dispensing allowed highly addictive drugs to reach abusers and be sold illegally.

Costco announced its plans to cooperate with the DEA's subpoenas and administrative inspection warrants in a filing with the U.S. Securities and Exchange Commission on Wednesday. It said the matter concerned its "fulfillment of prescriptions related to controlled substances and related practices."

Additional details were not provided, and company representatives declined to comment beyond what was included in the regulatory filing.

(Reporting by Jessica Wohl in Chicago; Editing by Leslie Adler and Bob Burgdorfer)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE I
12/06 WALGREENS BOOTS ALLIANCE : Aurora Health Care to Operate Retail Clinics in Walgr..
12/06 WALGREENS BOOTS ALLIANCE : Earns Best Place to Work for LGBT Equality Recognitio..
12/05 WALGREENS BOOTS ALLIANCE : Schedules Fiscal 2017 First Quarter Earnings Announce..
12/05 WALGREENS : Earns Best Place to Work for LGBT Equality Recognition in 2017 Corpo..
11/22 WALGREENS : Makes Life Saving Naloxone Available Without Prescription in Louisia..
11/17 INTERRA RESOURCES : Walgreens sues Theranos, alleging breach of contract
11/16DJWALGREENS BOOTS ALLIANCE : Claims Theranos Voided 11.3% of Test Reports
11/15 WALGREENS BOOTS ALLIANCE INC : ex-dividend day
11/10 Trump victory clouds outlook for Time Warner-AT&T, other mergers
11/09 Trump stand on AT&T/Time Warner not indicative of M&A policy - analysts
More news
Sector news : Drug Retailers - NEC
11/16DJTarget Draws Back Shoppers
11/10 Trump victory clouds outlook for Time Warner-AT&T, other mergers
11/09 Trump stand on AT&T/Time Warner not indicative of M&A policy - analysts
11/08DJCVS Warns of Prescriptions Shift, Shares Tumble
11/08DJCVS HEALTH : Warns of Prescriptions Shift, Shares Tumble on Profit Warning -- 2n..
More sector news : Drug Retailers - NEC
Advertisement
Financials ($)
Sales 2017 120 523 M
EBIT 2017 7 592 M
Net income 2017 4 768 M
Debt 2017 9 047 M
Yield 2017 1,78%
P/E ratio 2017 19,05
P/E ratio 2018 16,70
EV / Sales 2017 0,84x
EV / Sales 2018 0,78x
Capitalization 91 765 M
More Financials
Chart WALGREENS BOOTS ALLIANCE I
Duration : Period :
Walgreens Boots Alliance I Technical Analysis Chart | US9314221097 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 92,8 $
Spread / Average Target 9,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
George Rollo Fairweather Global Chief Financial Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIAN..-0.07%91 765
WALGREENS BOOTS ALLIAN..-0.52%91 765
CVS HEALTH CORP-18.77%84 697
EXPRESS SCRIPTS HOLDIN..-12.22%47 313
MCKESSON CORPORATION-26.28%32 873
CARDINAL HEALTH INC-20.00%22 859
More Results